title: Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolites.
abstract: The imidazoquinoline (R)-5,6-Dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine [(R)-3] is a potent dopamine agonist when tested in animals but surprisingly shows very low affinity in in vitro binding assays. When incubated with mouse or monkey liver S9 microsomes, (R)-3 is metabolized by N-demethylation and oxidation to (R)-5,6-dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H) -one [(R)-6], intermediate metabolites, where N-demethylation to the imidazoquinoline (R)-4 and where oxidation to the imidazoquinolinone (R)-5 has taken place, are also observed in these incubates. A cross-species study on the metabolism of (R)-3 in vitro has shown large variations in the extent of metabolism from species to species. Imidazoquinolinones (R)-5 and (R)-6 have comparable activity to (R)-3 in animals and also show good dopaminergic (D2) and serotonergic (5HT1A) activities in binding assays. It is probable that these metabolites account at least in part for the in vivo activity found for (R)-3. Efficient syntheses for compounds 3-6 as single enantiomers from quinoline are presented together with information on the biological activities and metabolic stabilities of these compounds.
authors.affiliation: Pharmacia & Upjohn, Inc., Kalamazoo, Michigan 49001-0199, USA.
authors.forename: R F
authors.initials: RF
authors.lastname: Heier
authors.forename: L A
authors.initials: LA
authors.lastname: Dolak
authors.forename: J N
authors.initials: JN
authors.lastname: Duncan
authors.forename: D K
authors.initials: DK
authors.lastname: Hyslop
authors.forename: M F
authors.initials: MF
authors.lastname: Lipton
authors.forename: I J
authors.initials: IJ
authors.lastname: Martin
authors.forename: M A
authors.initials: MA
authors.lastname: Mauragis
authors.forename: M F
authors.initials: MF
authors.lastname: Piercey
authors.forename: N F
authors.initials: NF
authors.lastname: Nichols
authors.forename: P J
authors.initials: PJ
authors.lastname: Schreur
authors.forename: M W
authors.initials: MW
authors.lastname: Smith
authors.forename: M W
authors.initials: MW
authors.lastname: Moon
mesh_terms: D000634:Aminoquinolines / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D018491:Dopamine Agonists / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D007093:Imidazoles / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D013058:Mass Spectrometry; D008744:Methylamines / Q000138:chemical synthesis / Q000494:pharmacology; D051379:Mice; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D015394:Molecular Structure; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D011954:Receptors, Dopamine / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism; D017366:Serotonin Receptor Agonists / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D013237:Stereoisomerism
chemical_list: C105119:5,6-dihydro-N,N-dimethyl-4H-imidazo(4,5-ij)quinolin-5-amine; D000634:Aminoquinolines; D018491:Dopamine Agonists; D007093:Imidazoles; D008744:Methylamines; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists